Hostname: page-component-84b7d79bbc-g7rbq Total loading time: 0 Render date: 2024-07-28T15:54:56.233Z Has data issue: false hasContentIssue false
  • English
  • Français

Late-onset liver abnormalities associated with long-term lofepramine treatment

Published online by Cambridge University Press:  13 June 2014

K Sayal  and
PA Cotter
PA Cotter
Affiliation:
Maudsley Hospital, Denmark Hill, London SE5 8AF, England
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters to the Editor
Information
Irish Journal of Psychological Medicine , Volume 13 , Issue 3 , September 1996 , pp. 124
Copyright
Copyright © Cambridge University Press 1996

References

1.Feighner, JP, Meredith, CH, Dutt, JE, Henrickson, G. A double-blind comparison of lofepramine, imipramine and placebo in patients with primary depression. Acta Psychiatrica Scand 1982; 66: 109–20.CrossRefGoogle Scholar
2. Anonymous. Lofepramine (Gamanil) and abnormal blood tests of liver function. Committee on Safety of Medicines. Current Problems 1988; 23: 371.Google Scholar
3.Kelly, C, Roche, S, Naguib, M, Webb, S, Roberts, M, Pitt, B. A prospective evaluation of the hepatotoxicity of lofepramine in the elderly. Int Clin Psychopharmacol 1993; 8: 83–6.CrossRefGoogle ScholarPubMed
4.Price, LH, Nelson, JC, Waltrip, RW. Desipramine-associated hepatitis. J Clin Psychopharmacol 1983; 3(4): 243–46.CrossRefGoogle ScholarPubMed
5.Lack, SJ, Baldwin, DS, Montgomery, SA. Lofepramine, desipramine and abnormal tests of liver function: a case report. Int Clin Psychopharmacol 1990; 5: 185–90.CrossRefGoogle ScholarPubMed